CoChat

Marine Oil Supplements for Arthritis Pain: A Systematic Review and Meta-Analysis of Randomized Trials

Open access

The DOI matches its Crossref record; 88 of the 94 references it cites were found in a registry or an index.

Abstract

Arthritis patients often take fish oil supplements to alleviate symptoms, but limited evidence exists regarding their efficacy. The objective was to evaluate whether marine oil supplements reduce pain and/or improve other clinical outcomes in patients with arthritis. Six databases were searched systematically (24 February 2015). We included randomized trials of oral supplements of all marine oils compared with a control in arthritis patients. The internal validity was assessed using the Cochrane Risk of Bias tool and heterogeneity was explored using restricted maximum of likelihood (REML)-based meta-regression analysis. Grading of Recommendations Assessment, Development and Evaluation (GRADE) was used to rate the overall quality of the evidence. Forty-two trials were included; 30 trials reported complete data on pain. The standardized mean difference (SMD) suggested a favorable effect (−0.24; 95% confidence interval, CI, −0.42 to −0.07; heterogeneity, I2 = 63%. A significant effect was found in patients with rheumatoid arthritis (22 trials; −0.21; 95% CI, −0.42 to −0.004) and other or mixed diagnoses (3 trials; −0.63; 95% CI, −1.20 to −0.06), but not in osteoarthritis patients (5 trials; −0.17; 95% CI, −0.57–0.24). The evidence for using marine oil to alleviate pain in arthritis patients was overall of low quality, but of moderate quality in rheumatoid arthritis patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/nu9010042

Cites

88 of 88 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Flow diagram showing the selection of trials. MA: meta-analysis, ICTRP: World Health Organization International Clinical Trial Registry Platform portal, SAE: serious adverse event.
Figure 1 Flow diagram showing the selection of trials. MA: meta-analysis, ICTRP: World Health Organization International Clinical Trial Registry Platform portal, SAE: serious adverse event.CC BY · PubMed Central
Figure 2 Risk of bias summary figure. : adequate methodology, : unclear methodology, : inadequate methodology. Risk of outcome reporting bias was not assessed for Vargová et al. (1998) [49], since only the abstract was available in English, and the rest of the article was not in English. Therefore, it was not considered appropriate to assess outcome reporting bias based only on the abstract of a full article.
Figure 2 Risk of bias summary figure. : adequate methodology, : unclear methodology, : inadequate methodology. Risk of outcome reporting bias was not assessed for Vargová et al. (1998) [49], since only the abstract was available in English, and the rest of the article was not in English. Therefore, it was not considered appropriate to assess outcome reporting bias based only on the abstract of a full article.CC BY · PubMed Central
Figure 3 Forest plot of the effect size for marine oil interventions on pain. Weights are shown for both a random-effects model (“W(random)”) and a fixed-effects model (“W(fixed)”). 95% CI: 95% confidence interval; MO: marine oil; SMD: standardized mean differences. Note that the use of the term MO refers to all oils of marine origin (e.g., oil from whole fish and mussel oil).
Figure 3 Forest plot of the effect size for marine oil interventions on pain. Weights are shown for both a random-effects model (“W(random)”) and a fixed-effects model (“W(fixed)”). 95% CI: 95% confidence interval; MO: marine oil; SMD: standardized mean differences. Note that the use of the term MO refers to all oils of marine origin (e.g., oil from whole fish and mussel oil).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 88 references

Research works printed but not linked: 11

  1. Darlington L.G. Ramsey N.W. Olive oil for rheumatoid patients? Br. J. Rheumatol. 1987 26 129
  2. Tulleken J.E. Limburg P.C. Muskiet F.A.J. Kazemier K.M. Van Rijswijk M.H. A Comparison between the Effects of Fish Oil Ethyl Esters and Fish Oil Triglycerides in Rheumatoid Arthritis, Long Chain Omega-3 Polyunsaturated Fatty Acids in Rheumatoid Arthritis Thesis Rijksuniversiteit Groningen Groningen, The Netherlands 1991
  3. Tulleken J.E. Limburg P.C. Wassenaar W. Van Rijswijk M.H. Nonsteroidal Anti-Inflammatory Drug Demand during Fish Oil Treatment in Rheumatoid Arthritis, Long Chain Omega-3 Polyunsaturated Fatty Acids in Rheumatoid Arthritis Thesis Rijksuniversiteit Groningen Groningen, The Netherlands 1991
  4. Nielsen G.L. Faarvang K.L. Thomsen B.S. Teglibjaerg K.L. Ernst E. Effects of supplementation with n-3 fatty acids on clinical disease variables in patients with rheumatoid arthritis Eur. J. Clin. Invest. 1991 21 67 1459173
  5. Araújo C.A. Moraes-Fontes M.F. Santos L. Riso N. Omega-3 fatty acids and mediterranean diet as complimentary therapies for rheumatoid arthritis Arthritis Rheumatol. 2014 66 S1050
  6. Hernández-Cruz B. Alcocer-Varela J. Cardiel M.H. Omega-3 fatty acids supplementation in Mexican patients with rheumatoid arthritis with standard treatment. A blinded, randomized, placebo controlled, one year, clinical trial Arthritis Rheum. 1998 41 S155
  7. Kremer J. Larence D. Jubiz W. Digarcomo R. Rynes R. Bartholomew L. Different doses of fish-oil fatty acid supplementation in rheumatoid arthritis ra a prospective double-blinded randomized study Arthritis Rheum. 1988 31 S303
  8. Kremer J.M. Lawrence D.A. Stocker R.S. Rynes R.I. Parhami N. Greenstein N.S. Petrillo G.F. Simon L.S. Robinson D.W. Clinical, immunological and nsaid sparing effects of fish-oil (fo) in patients with active rheumatoid-arthritis (ra)-a long-term prospective randomized double-blind-study Arthritis Rheum. 1993 36 S56
  9. Lau C.S. McMahon H. Morley K.D. Belch J.J.F. Effects of maxepa on non-steroidal anti-inflammatory drug usage in patients with mild rheumatoid arthritis Br. J. Rheumatol. 1991 30 137 8220938
  10. Kolahi S. Haghjoo A.G. Effect of fish oil supplements on serum paraoxonase activity in patients with rheumatoid arthritis Rheumatology (Oxf., Engl.) 2012 51 i31 22924372
  11. Yazdanpanah P. Mohamadi H. Sadeghi H. Ghaffarian Shirazi H. Arjmand A. Survey of omega-3 effects on morning stiffness in osteoarthritis of the knee Pain Pract. 2014 14 126

Cited by

See all 115

Metadata

Authors
Senftleber, N., Nielsen, S., Andersen, J., Bliddal, H., Tarp, S., Lauritzen, L., Furst, D., Suarez-Almazor, M., Lyddiatt, A., & Christensen, R.
Affiliations
  • University of Copenhagen (DK)
  • Frederiksberg Hospital (DK)
  • Division of Rheumatology, University of California, Los Angeles, CA 90095, USA
  • The University of Texas MD Anderson Cancer Center (US)
  • Cochrane Canada (CA)
Corresponding author
Christensen, Robin
Venue
Nutrients
Publisher
MDPI AG
Published
2017-01-06
Volume
9
Issue
1
Pages
42
ISSN
2072-6643 (ISSN-L)
OpenAlex
W2570262414
Cited by
114
References
94
Citations by year
2026: 6 · 2025: 7 · 2024: 10 · 2023: 9 · 2022: 15 · 2021: 16 · 2020: 16 · 2019: 16 · 2018: 14 · 2017: 4
FWCI
1.41
Type
journal article
Language
en
Open access
Locations
  • Nutrients (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
  • Informationszentrum Lebenswissenschaften (ZB MED) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
Funders
  • The Oak Foundation ((indirect funding))
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (K24 AR053593 (M.E. Suarez-Almazor received a Midcareer Investigator Award))
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
  • Health Sciences › Medicine › Rheumatology › Osteoarthritis Treatment and Mechanisms
Keywords
fish oil, arthritis, rheumatoid arthritis, osteoarthritis, analgesia, omega-3 fatty acids, dietary supplements
MeSH terms
Arthritis, Rheumatoid, Docosahexaenoic Acids, Fish Oils, Humans, Inflammation, Osteoarthritis, Pain, Eicosapentaenoic Acid, Randomized Controlled Trials as Topic, Databases, Factual, Treatment Outcome, alpha-Linolenic Acid, Dietary Supplements

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.